Automated Pupillometry for Coma Prognostication After Cardiac Arrest
NCT ID: NCT02607878
Last Updated: 2021-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
470 participants
OBSERVATIONAL
2015-01-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim of the study: In light of these promising results, the investigators would like to confirm the prognostic value of quantitative PLR in a large multicenter cohort of comatose post-CA patients.
Design of the study: Prospective, multicenter, observational outcome trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Point of Care System for Automated Coma Prognosis
NCT03826407
Continuous Quantified EEG in NeuroIntensive Care
NCT02901262
Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest
NCT06048796
Aiming for a Better Understanding and Improvement of the Diagnosis and Prognosis of Patients With Disorders of Consciousness Through Multimodal Observations
NCT04798456
Families Expectations and Hope Raised by an Evaluation of Consciousness in Patients in a Vegetative State
NCT02879565
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patient population:
The investigators plan to include 500 comatose post-CA patients. The centers have been selected based on their expertise and publication track record on the topic, and because they are actively involved in the Neurointensive Care section (NIC) of the European Society of Intensive Care Medicine (ESICM). The study will take place at the Department of Intensive Care of the participating centers.
Patients will be managed according to standards of post-resuscitation care and based on local algorithms for the treatment of post-CA coma.
Quantitative pupillary light reactivity (PLR, using the NeurOptics NPi-200 pupillometer) will be performed on ICU admission and then every 12 hours up to 72 hours after CA. At each time point, one measurement will be assessed on both eyes.
The primary variables for analysis will be the neurological pupil index (NPi) and the pupil size for both eyes. Standard PLR using a manual pen light will be performed simultaneously at each time point, as part of standard care.
EEG, SSEP and sampling for serum neuron specific enolase (NSE) will be performed at 24h and at 48-72h, according to local practices and as part of standard care.
The predictive value of NPi will be analyzed using the area under the receiving operator characteristics (ROC) curve, and compared to that of standard PLR, EEG, SSEP and NSE: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), unweighted accuracy, with 95% binomial confidence intervals, will be calculated. Associations with outcome will adjusted for main baseline demographics (age, initial CA arrest rhythm, time from CA to tROSC), dose of sedation-analgesia and vaso-active agents, and the SOFA score, using a logistic regression model.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Glasgow Coma Scale (at inclusion): ≤ 6
* Patients with CA due to ventricular fibrillation (VF) and non-VF (including asystole and pulseless electrical activity) rhythms
* Cardiac and non-cardiac causes of CA will be included
Exclusion Criteria
* Unable to obtain consent
* Follow-up unavailable
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasme University Hospital
OTHER
Azienda Ospedaliera San Gerardo di Monza
OTHER
Lund University Hospital
OTHER
University Hospital, Grenoble
OTHER
Catholic University of the Sacred Heart
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Cochin University Hospital, Paris
UNKNOWN
Charite University, Berlin, Germany
OTHER
Centre Hospitalier du Luxembourg
OTHER
Centre Hospitalier Universitaire Vaudois
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mauro ODDO
Médecin adjoint, PD-MER I
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mauro Oddo, MD
Role: PRINCIPAL_INVESTIGATOR
CHUV, Lausanne University Hospital, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erasme University Hospital
Brussels, , Belgium
University Hospital, Grenoble
Grenoble, , France
Cochin Hospital
Paris, , France
Charite University, Berlin, Germany
Berlin, , Germany
Azienda Ospedaliera San Gerardo di Monza
Monza, , Italy
Catholic University of the Sacred Heart
Roma, , Italy
Centre Hospitalier du Luxembourg
Luxembourg, , Luxembourg
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam, , Netherlands
Lund University Hospital
Lund, , Sweden
CHUV, Lausanne University Hospital
Lausanne, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
432/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.